How much is Patara Pharma worth in 2026?

Patara Pharma has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Patara Pharma raised?

Patara Pharma has raised N/A in total funding across 1 funding rounds.

Patara Pharma

Other Pharmaceuticals and Biotechnology

Patara Pharma valuation and funding history | Last updated: September 4, 2018 | 1 funding rounds

Current Valuation

N/A

As of September 4, 2018

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Sep 2018

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 4, 2018	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Patara Pharma is currently valued at N/A as of September 4, 2018.

Track Patara Pharma Valuation Updates

Get notified when Patara Pharma raises new funding or valuation changes

Explore More Data

Detailed analysis for Patara Pharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Patara Pharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is Patara Pharma Worth in 2026?

Patara Pharma is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Patara Pharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Patara Pharma Valuation is Determined

Private company valuations like Patara Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.